A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol

Clinical Trial ID NCT01540708

Rank	Title	Journal	Year	PubWeight™‹?›
1	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.	N Engl J Med	2007	19.86
2	Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.	Eur Respir J	2004	16.84
3	A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.	J Pharmacokinet Biopharm	1987	8.01
4	Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.	Am J Respir Crit Care Med	2006	4.82
5	Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003.	COPD	2004	3.14
6	Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure.	Drug Metab Dispos	2009	1.95
7	Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.	Respir Med	2008	1.89